These results are strengthened by the observational study conducted by Liu et al., as they found an optimal cut-off value for PTX-3 (12.6 ng/mL, 68% sensitivity and 71.7%, specificity) to identify colorectal cancer patients with a poorer 5-year overall survival rate [94]. This evidence concerns the gene PTX3 and colorectal cancer.